PFC Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Buy
10,800
+582
+6% +$136K 1.05% 27
2026
Q1
$2.5M Buy
10,218
+470
+5% +$109K 1.1% 26
2025
Q4
$2.02M Sell
9,748
-63
-0.6% -$12.5K 0.83% 31
2025
Q3
$1.82M Sell
9,811
-778
-7% -$133K 0.76% 31
2025
Q2
$1.62M Sell
10,589
-1,404
-12% -$216K 0.75% 35
2025
Q1
$1.99M Sell
11,993
-843
-7% -$132K 1% 24
2024
Q4
$1.86M Sell
12,836
-2,175
-14% -$337K 0.9% 26
2024
Q3
$2.43M Sell
15,011
-2,714
-15% -$432K 1.17% 20
2024
Q2
$2.59M Sell
17,725
-3,715
-17% -$553K 1.3% 17
2024
Q1
$3.39M Sell
21,440
-1,390
-6% -$221K 1.82% 16
2023
Q4
$3.58M Buy
+22,830
New +$3.5M 2.12% 14

Other funds holding JNJ

PFC Capital Group's JNJ Position: Q2 2026 in Review

PFC Capital Group increased its Johnson & Johnson (JNJ) stake by 5.7% in Q2 2026, buying an estimated $136K and bringing the position to 10,800 shares worth $2.74M. The position accounts for 1.05% of the portfolio, ranked #27.

PFC Capital Group first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.58M in Q4 2023. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • PFC Capital Group held 10,800 shares of Johnson & Johnson worth $2.74M as of Q2 2026.
  • PFC Capital Group bought 582 Johnson & Johnson shares in Q2 2026, an estimated $136K.
  • Johnson & Johnson made up 1.05% of PFC Capital Group's portfolio in Q2 2026, its #27 holding.
  • PFC Capital Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • PFC Capital Group's Johnson & Johnson position peaked at $3.58M in Q4 2023.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on PFC Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.